Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Expert Consensus For Multi-modality Imaging Evaluation Of Cardiovascular Complications Of Radiotherapy In Adults: A Report From The European Association Of Cardiovascular Imaging And The American Society Of Echocardiography.

P. Lancellotti, V. Nkomo, L. Badano, J. Bergler-Klein, J. Bogaert, L. Davin, B. Cosyns, P. Coucke, R. Dulgheru, T. Edvardsen, O. Gaemperli, M. Galderisi, B. Griffin, P. Heidenreich, K. Nieman, J. Plana, S. Port, M. Scherrer‐Crosbie, R. G. Schwartz, I. Sebag, J. Voigt, Samuel Wann, P. Yang
Published 2013 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Cardiac toxicity is one of the most concerning side effects of anti-cancer therapy. The gain in life expectancy obtained with anti-cancer therapy can be compromised by increased morbidity and mortality associated with its cardiac complications. While radiosensitivity of the heart was initially recognized only in the early 1970s, the heart is regarded in the current era as one of the most critical dose-limiting organs in radiotherapy. Several clinical studies have identified adverse clinical consequences of radiation-induced heart disease (RIHD) on the outcome of long-term cancer survivors. A comprehensive review of potential cardiac complications related to radiotherapy is warranted. An evidence-based review of several imaging approaches used to detect, evaluate, and monitor RIHD is discussed. Recommendations for the early identification and monitoring of cardiovascular complications of radiotherapy by cardiac imaging are also proposed.
This paper references
10.1093/ejechocard/jer021
Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography.
V. Mor-Avi (2011)
The prevalence of myocardial ischemia after concurrent chemoradiation therapy as detected by gated myocardial perfusion imaging in patients with esophageal cancer.
I. Gayed (2006)
10.1136/heartjnl-2012-302239
Drug-induced valvular heart disease
B. Cosyns (2012)
10.1016/S0140-6736(05)67887-7
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
M. Clarke (2005)
10.1016/J.AMJCARD.2004.01.044
Relation of coronary calcium scores by electron beam tomography to obstructive disease in 2,115 symptomatic patients.
A. Knez (2004)
10.1016/J.JACC.2006.07.003
ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging. A report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group.
R. Hendel (2006)
10.1093/ejechocard/jer257
The role of multi-imaging modality in primary mitral regurgitation.
C. M. Van de Heyning (2012)
10.1093/ejechocard/jeq031
European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease).
P. Lancellotti (2010)
10.1016/S1470-2045(05)70251-5
Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries.
S. Darby (2005)
10.1007/s12350-010-9215-5
Reduced isotope dose with rapid SPECT MPI imaging: Initial experience with a CZT SPECT camera
W. Duvall (2010)
10.1161/CIRCULATIONAHA.111.026070
Cardiac Magnetic Resonance Imaging Pericardial Late Gadolinium Enhancement and Elevated Inflammatory Markers Can Predict the Reversibility of Constrictive Pericarditis After Antiinflammatory Medical Therapy: A Pilot Study
D. Feng (2011)
10.1016/J.IJROBP.2005.01.029
The incidence and functional consequences of RT-associated cardiac perfusion defects.
L. Marks (2005)
10.1016/j.acra.2007.08.012
Diagnostic performance of positron emission tomography in the detection of coronary artery disease: a meta-analysis.
K. Nandalur (2008)
10.1161/HC0402.102975
Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.
M. Cerqueira (2002)
10.1007/s00330-005-0009-0
Assessment of ventricular coupling with real-time cine MRI and its value to differentiate constrictive pericarditis from restrictive cardiomyopathy
M. Francone (2005)
10.1016/S0735-1097(03)00759-9
Asymptomatic cardiac disease following mediastinal irradiation.
P. Heidenreich (2003)
10.1093/EURHEARTJ/EHM311
Radiotherapy effects on systolic myocardial function detected by strain rate imaging in a left-breast cancer patient.
R. Jurcut (2007)
10.1089/ars.2010.3742
Radiation as a risk factor for cardiovascular disease.
J. E. Baker (2011)
10.1056/nejmra061889
Coronary microvascular dysfunction.
P. Camici (2007)
10.1148/rg.311105049
Evaluation of left ventricular diastolic function with cardiac MR imaging.
J. Caudron (2011)
10.1016/J.IJROBP.2006.08.071
Radiation-induced cardiovascular diseases: is the epidemiologic evidence compatible with the radiobiologic data?
Susanne Schultz-Hector (2007)
10.1016/J.EUJE.2003.07.001
American Society of Echocardiography: recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography
W. Zoghbi (2003)
10.1111/j.1540-8175.2008.00878.x
Echocardiographic Manifestations of Complications of Radiation Therapy
A. Hamza (2009)
10.1667/RR1862.1
Vascular Damage as an Underlying Mechanism of Cardiac and Cerebral Toxicity in Irradiated Cancer Patients
F. Stewart (2010)
10.1093/eurheartj/ehs109
Guidelines on the management of valvular heart disease (version 2012).
A. Vahanian (2012)
10.1200/JCO.1998.16.11.3493
Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients.
C. Shapiro (1998)
10.1016/j.echo.2011.11.010
EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography.
R. Lang (2012)
10.1007/BF00168163
Myocardial perfusion damage after mediastinal irradiation for Hodgkin's disease: a thallium-201 single photon emission tomography study
C. Maunoury (2004)
10.1093/ejechocard/jen204
Late occurrence of fatal aortitis: a complication of Aspergillus endocarditis following coronary artery bypass graft surgery.
M. Esmaeilzadeh (2009)
10.1016/S0735-1097(99)00551-3
Importance of imaging method over imaging modality in noninvasive determination of left ventricular volumes and ejection fraction: assessment by two- and three-dimensional echocardiography and magnetic resonance imaging.
M. Chuang (2000)
10.1016/J.EJCTS.2006.02.066
Investigating myocardial motion by MRI using tissue phase mapping.
B. Jung (2006)
10.1002/cncr.11407
Congestive heart failure in patients treated with doxorubicin
S. Swain (2003)
10.1016/S0360-3016(97)00467-7
Cardiac function, perfusion, and morbidity in irradiated long-term survivors of Hodgkin's disease.
L. Constine (1997)
10.1200/JCO.2009.25.2627
Evaluation of coronary artery disease by computed tomography angiography in patients treated for childhood Hodgkin's lymphoma.
S. Küpeli (2010)
10.4061/2011/317659
Radiation-Induced Heart Disease: A Clinical Update
S. Yusuf (2011)
10.1007/s10554-009-9440-7
The clinical implications of myocardial perfusion abnormalities in patients with esophageal or lung cancer after chemoradiation therapy
I. Gayed (2009)
10.1007/978-3-642-23035-6
Clinical cardiac MRI
J. Bogaert (2005)
10.1093/ejechocard/jen303
Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice.
H. Baumgartner (2009)
10.1016/0002-9343(87)90212-9
Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography.
R. G. Schwartz (1987)
10.1016/j.ejca.2011.05.023
Systolic and diastolic dysfunction in long-term adult survivors of childhood cancer.
C. A. Brouwer (2011)
10.1200/JCO.2007.10.9777
American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects.
J. Carver (2007)
10.1148/RADIOLOGY.218.1.R01JA50215
An improved MR imaging technique for the visualization of myocardial infarction.
O. Simonetti (2001)
10.1016/j.jacc.2010.02.047
Assessment of nonischemic myocardial fibrosis.
C. Jellis (2010)
10.1016/j.ijrobp.2009.12.054
Cardiac magnetic resonance imaging findings in 20-year survivors of mediastinal radiotherapy for Hodgkin's disease.
W. Machann (2011)
10.1093/med/9780199599639.001.0001
The EAE textbook of echocardiography
L. Galiuto (2011)
10.1016/0360-3016(93)90317-O
Follow-up thallium-201 scintigraphy after mantle field radiotherapy for Hodgkin's disease.
J. Pierga (1993)
10.1016/j.jcmg.2011.07.010
Simultaneous right and left heart real-time, free-breathing CMR flow quantification identifies constrictive physiology.
P. Thavendiranathan (2012)
10.1001/JAMA.290.21.2831
Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy.
Matthew C. Hull (2003)
10.1016/J.IJROBP.2007.03.033
Impact of fraction size on cardiac mortality in women treated with tangential radiotherapy for localized breast cancer.
W. Marhin (2007)
10.1148/radiol.11110638
Detection of hemodynamically significant coronary artery stenosis: incremental diagnostic value of dynamic CT-based myocardial perfusion imaging.
F. Bamberg (2011)
10.1093/ejechocard/jep007
Recommendations for the evaluation of left ventricular diastolic function by echocardiography.
S. Nagueh (2009)
10.1148/RADIOL.2282020345
Clinically suspected constrictive pericarditis: MR imaging assessment of ventricular septal motion and configuration in patients and healthy subjects.
B. Giorgi (2003)
10.1016/j.jacc.2008.10.014
ACC/AHA classification of care metrics: performance measures and quality metrics: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.
Robert O. Bonow (2008)
10.1016/j.echo.2011.05.004
Clinical validation of a novel speckle-tracking-based ejection fraction assessment method.
M. Szulik (2011)
10.1016/S0046-8177(96)90447-5
Pathology of radiation-induced heart disease: a surgical and autopsy study of 27 cases.
J. Veinot (1996)
10.5167/UZH-25533
Evaluation of aortic valve stenosis by cardiac multislice computed tomography compared with echocardiography: a systematic review and meta-analysis.
J. Abdulla (2009)
10.1007/s11547-010-0594-0
Utility of T2-weighted short-tau inversion recovery (STIR) sequences in cardiac MRI: an overview of clinical applications in ischaemic and non-ischaemic heart disease
M. Francone (2010)
10.2214/AJR.173.4.10511167
Three-dimensional MR angiography in the evaluation of thoracic outlet syndrome.
S. Dymarkowski (1999)
10.1200/JCO.2011.40.3584
Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imaging.
G. Armstrong (2012)
10.1093/EURHEARTJ/EHI258
Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies.
H. Mahrholdt (2005)
10.1378/CHEST.85.3.367
Mitral anular calcification in chronic renal failure.
M. Forman (1984)
10.1136/hrt.75.6.591
Increased risk of heart valve regurgitation after mediastinal radiation for Hodgkin's disease: an echocardiographic study.
M. Lund (1996)
10.1002/jmri.21759
Strain‐encoded cardiac MR during high‐dose dobutamine stress testing: Comparison to cine imaging and to myocardial tagging
G. Korosoglou (2009)
10.1016/j.amjcard.2009.07.011
Comparison of the value of coronary calcium detection to computed tomographic angiography and exercise testing in patients with chest pain.
K. Nieman (2009)
10.1093/EURHEARTJ/EHL428
Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology.
A. Vahanian (2007)
10.1148/radiol.2482071478
Comprehensive assessment of myocardial perfusion defects, regional wall motion, and left ventricular function by using 64-section multidetector CT.
R. Cury (2008)
10.1161/CIRCIMAGING.111.966796
Assessment of Diffuse Myocardial Fibrosis in Rats Using Small-Animal Look-Locker Inversion Recovery T1 Mapping
D. Messroghli (2011)
10.1016/j.echo.2008.11.023
Recommendations for the evaluation of left ventricular diastolic function by echocardiography.
S. Nagueh (2009)
10.1148/RADIOLOGY.219.1.R01AP12264
MR evaluation of ventricular function: true fast imaging with steady-state precession versus fast low-angle shot cine MR imaging: feasibility study.
J. Barkhausen (2001)
10.1081/JCMR-65639
How we perform cardiovascular magnetic resonance flow assessment using phase-contrast velocity mapping.
P. Chai (2005)
10.1200/JCO.2003.07.131
Long-term cause-specific mortality of patients treated for Hodgkin's disease.
B. Aleman (2003)
10.1016/J.PCAD.2006.08.008
Systolic dysfunction in heart failure with normal ejection fraction: speckle-tracking echocardiography.
T. Edvardsen (2006)
10.1200/JCO.2004.09.109
Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy.
M. Adams (2004)
10.2214/AJR.07.3112
Coronary artery disease after radiation therapy for Hodgkin's lymphoma: coronary CT angiography findings and calcium scores in nine asymptomatic patients.
J. Rademaker (2008)
10.1016/0002-9343(79)90452-2
Calcification of the mitral annulus: etiology, clinical associations, complications and therapy.
P. Fulkerson (1979)
10.1016/J.ATHORACSUR.2007.06.034
Quality of internal thoracic artery grafts after mediastinal irradiation.
B. Gansera (2007)
10.1161/STROKEAHA.111.615203
Ischemic Stroke and Transient Ischemic Attack After Head and Neck Radiotherapy: A Review
C. Plummer (2011)
10.1056/NEJMoa1111961
ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma.
R. Meyer (2012)
10.1016/S0002-9149(02)02381-0
Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy.
F. Grothues (2002)
10.1161/CIRCULATIONAHA.113.001435
Long-Term Survival of Patients With Radiation Heart Disease Undergoing Cardiac Surgery: A Cohort Study
W. Wu (2013)
10.1093/ejechocard/jen258
Using mitral 'annulus reversus' to diagnose constrictive pericarditis.
Christina S. Reuss (2009)
10.1016/0167-8140(94)90008-6
Cardiac lesions after mediastinal irradiation for Hodgkin's disease.
C. Glanzmann (1994)
10.1161/CIR.0b013e31823ac046
Heart disease and stroke statistics--2012 update: a report from the American Heart Association.
V. Roger (2012)
10.4061/2011/858262
Preclinical Research into Basic Mechanisms of Radiation-Induced Heart Disease
M. Boerma (2010)
10.1016/S0894-7317(03)00335-3
Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography.
W. Zoghbi (2003)
10.1016/S0140-6736(11)61335-4
Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial
J. Greenwood (2012)
10.1093/ejechocard/jen174
European Association of Echocardiography recommendations for standardization of performance, digital storage and reporting of echocardiographic studies.
A. Evangelista (2008)
10.1136/hrt.69.6.496
Severe coronary artery disease after radiation therapy of the chest and mediastinum: clinical presentation and treatment.
F. Orzan (1993)
10.1016/J.AMJCARD.2006.10.063
Acute cardiac functional and morphological changes after Anthracycline infusions in children.
J. Ganame (2007)
10.1016/j.echo.2009.08.006
Radiotherapy-induced mitral stenosis: a three-dimensional perspective.
M. Malanca (2010)
10.1016/J.JACC.2003.08.011
ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionucl
F. Klocke (2003)
10.1161/CIRCIMAGING.112.973321
Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab
Heloisa Sawaya (2012)
10.1016/J.AHJ.2004.12.026
Diastolic dysfunction after mediastinal irradiation.
P. Heidenreich (2005)
10.1148/RADIOLOGY.199.1.8633172
"Black blood" T2-weighted inversion-recovery MR imaging of the heart.
O. Simonetti (1996)
10.7326/0003-4819-154-6-201103150-00007
Meta-analysis: Diagnostic Performance of Low-Radiation-Dose Coronary Computed Tomography Angiography
M. W. von Ballmoos (2011)
10.1136/hrt.67.3.236
Aortic and mitral valve disease in patients with end stage renal failure on long-term haemodialysis.
E. Straumann (1992)
10.1186/1471-2261-11-32
A systematic review of the clinical effectiveness of 64-slice or higher computed tomography angiography as an alternative to invasive coronary angiography in the investigation of suspected coronary artery disease
Daniel C Paech (2011)
10.1016/S0002-9149(03)00546-0
Echocardiographic features of radiation-associated valvular disease.
D. Hering (2003)
10.1016/S0894-7317(98)70132-4
Stress echocardiography: recommendations for performance and interpretation of stress echocardiography. Stress Echocardiography Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography.
W. Armstrong (1998)
10.1093/eurheartj/ehq150
Imaging of coronary atherosclerosis by computed tomography.
S. Achenbach (2010)
10.1161/CIRCULATIONAHA.105.521450
Contrast-Enhanced Multidetector Computed Tomography Viability Imaging After Myocardial Infarction: Characterization of Myocyte Death, Microvascular Obstruction, and Chronic Scar
A. Lardo (2006)
10.2214/AJR.08.1098
New Challenges, New Opportunities
T. Berquist (2008)
10.1001/JAMA.1993.03510160067031
Factors affecting late mortality from heart disease after treatment of Hodgkin's disease.
S. Hancock (1993)
10.2214/AJR.07.3432
64-MDCT for diagnosis of aortic regurgitation in patients referred to CT coronary angiography.
G. Feuchtner (2008)
10.1136/hrt.2008.149088
Radiation induced heart disease
P. Heidenreich (2009)
10.1200/JCO.2006.07.0805
Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease.
P. Heidenreich (2007)
10.1016/S0360-3016(96)00295-7
Symptomatic coronary artery disease after mantle irradiation for Hodgkin's disease.
V. King (1996)
10.1016/j.amjcard.2010.09.048
Left ventricular function assessed by two-dimensional speckle tracking echocardiography in long-term survivors of Hodgkin's lymphoma treated by mediastinal radiotherapy with or without anthracycline therapy.
H. Tsai (2011)
10.1007/s00330-005-0025-0
Detection of pericardial inflammation with late-enhancement cardiac magnetic resonance imaging: initial results
A. Taylor (2005)
10.1016/j.jcmg.2011.08.011
Pericardial delayed hyperenhancement with CMR imaging in patients with constrictive pericarditis undergoing surgical pericardiectomy: a case series with histopathological correlation.
Andrew O. Zurick (2011)
10.2214/AJR.07.3022
Assessment of global right ventricular function on 64-MDCT compared with MRI.
C. Plumhans (2008)
10.1148/RADIOLOGY.169.1.3420283
Human heart: tagging with MR imaging--a method for noninvasive assessment of myocardial motion.
E. Zerhouni (1988)
10.2353/AJPATH.2006.050409
Ionizing radiation accelerates the development of atherosclerotic lesions in ApoE-/- mice and predisposes to an inflammatory plaque phenotype prone to hemorrhage.
F. Stewart (2006)
10.1016/j.ijrobp.2009.09.064
Radiation-related heart disease: current knowledge and future prospects.
S. Darby (2010)
10.1056/NEJMoa1209825
Risk of ischemic heart disease in women after radiotherapy for breast cancer.
S. Darby (2013)
10.1016/j.ijrobp.2010.01.004
Acute radiation effects on cardiac function detected by strain rate imaging in breast cancer patients.
K. Erven (2011)
10.1161/CIRCULATIONAHA.109.930636
Equilibrium Contrast Cardiovascular Magnetic Resonance for the Measurement of Diffuse Myocardial Fibrosis: Preliminary Validation in Humans
A. Flett (2010)
10.1200/JCO.2002.20.5.1215
Cardiac dysfunction in the trastuzumab clinical trials experience.
A. Seidman (2002)
10.1136/pgmj.71.833.164
Late cardiac effects after treatment for childhood Hodgkin's disease with chemotherapy and low-dose radiotherapy.
I. Ilhan (1995)
10.1186/1532-429X-11-56
T2 quantification for improved detection of myocardial edema
S. Giri (2009)
10.1161/01.CIR.0000133187.74800.B9
Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management.
E. T. Yeh (2004)
10.1093/ejechocard/jen175
Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC).
R. Sicari (2008)
10.1093/ehjci/jes139
Altered left ventricular longitudinal diastolic function correlates with reduced systolic function immediately after anthracycline chemotherapy.
P. Stoodley (2013)
10.1093/ejechocard/jep005
Contrast echocardiography: evidence-based recommendations by European Association of Echocardiography.
R. Senior (2009)
10.1093/JNCI/DJK064
Long-term risk of cardiovascular disease in 10-year survivors of breast cancer.
M. Hooning (2007)



This paper is referenced by
Long-term cardiac function in breast cancer survivors after multimodal treatment
Kristin Holm Tjessem (2016)
Title Cardiac Complications in the Adult Bone Marrow Transplant Patient Permalink
Mirela Tuzovic (2019)
10.1016/j.hfc.2016.12.004
Management of Heart Failure in Cancer Patients and Cancer Survivors.
J. E. Finet (2017)
10.1007/978-3-319-93402-0_7
Heart Failure and Left Ventricular Dysfunction
G. Novo (2019)
10.1016/J.RECESP.2017.01.025
Fundamentos de las unidades de cardio-oncología
L. Nhola (2017)
10.1007/s11936-014-0317-2
Radiation-Induced Heart Disease: An Under-Recognized Entity?
M. Davis (2014)
10.1002/ejhf.1741
How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
B. Pieske (2020)
10.1093/ehjci/jet084
The year 2012 in the European Heart Journal-Cardiovascular Imaging. Part II.
S. Plein (2013)
10.1093/ehjci/jev024
EACVI/HFA Cardiac Oncology Toxicity Registry in breast cancer patients: rationale, study design, and methodology (EACVI/HFA COT Registry)--EURObservational Research Program of the European Society of Cardiology.
P. Lancellotti (2015)
10.1016/j.rec.2017.02.006
Rationale for Cardio-Oncology Units.
L. Nhola (2017)
10.1016/j.ctrv.2017.11.006
Proton therapy for locally advanced breast cancer: A systematic review of the literature.
E. Kammerer (2018)
10.1007/978-3-319-43096-6_13
Future Clinical and Professional Directions in Cardio-oncology
A. Barac (2017)
10.1016/j.currproblcancer.2018.05.008
Cardiovascular effects of radiation therapy.
Merna A Armanious (2018)
10.1007/s11886-020-01373-3
The Role of Echocardiography in the Cancer Patient
Nicolas L. Palaskas (2020)
Structural Heart The Journal of the Heart Team
P. Lancellotti (2017)
10.1016/j.cdtm.2019.12.007
Optimal management of coronary artery disease in cancer patients
Xue-jie Han (2019)
10.1016/j.jacc.2019.07.006
Prevention, Diagnosis, and Management of Radiation-Associated Cardiac Disease: JACC Scientific Expert Panel.
M. Desai (2019)
10.1016/j.echo.2015.02.001
Time Trends of Left Ventricular Ejection Fraction and Myocardial Deformation Indices in a Cohort of Women with Breast Cancer Treated with Anthracyclines, Taxanes, and Trastuzumab.
T. Tan (2015)
10.1016/j.jaccao.2020.04.011
Magnetic Resonance Imaging to Detect Cardiovascular Effects of Cancer Therapy: JACC CardioOncology State-of-the-Art Review
I. Harries (2020)
10.2217/FCA.15.40
Strain imaging to detect cancer therapeutics-related cardiac dysfunction: are we there yet?
P. Collier (2015)
10.12688/f1000research.15190.1
Protecting the heart in cancer therapy
J. E. Finet (2018)
10.1016/j.ijcard.2016.08.219
Cardio-oncology, Immuno-oncology, Onco-cardiology and Onco-immunology.
N. Kounis (2016)
10.1016/j.amjcard.2016.08.050
Meta-Analysis of Association Between Mediastinal Radiotherapy and Long-Term Heart Failure.
M. Nolan (2016)
10.1016/B978-0-12-802509-3.00022-4
Nuclear Medicine Imaging and Cardiotoxicity
P. Erba (2017)
10.1080/24725579.2020.1795012
Detecting spatial susceptibility to cardiac toxicity of radiation therapy for lung cancer
Xiaonan Liu (2020)
Current treatment options in oncology , 20 ( 6 ) ISSN 1534-6277
Michael E. Layoun (2019)
10.2217/fon.15.128
Optimizing cardio-oncology programs for cancer patients.
S. Francis (2015)
10.1016/j.ultrasmedbio.2018.09.012
Prognostic and Added Value of Echocardiographic Strain for Prediction of Adverse Outcomes in Patients with Locally Advanced Non-Small Cell Lung Cancer after Radiotherapy.
Lu Chen (2019)
10.1007/s11883-017-0685-7
The Use of Primary Prevention Statin Therapy in Those Predisposed to Atherosclerosis
M. Garshick (2017)
10.2217/fon.15.129
Radiation-related heart and vascular disease.
S. Yusuf (2015)
10.1016/S1261-694X(14)70689-3
Pratique de l’échocardiographie : place de la délégation de compétence: Réflexions de la filiale d’échocardiographie de la Société française de cardiologie
E. Donal (2014)
10.3389/fonc.2020.01169
A Prospective Study of Early Radiation Associated Cardiac Toxicity Following Neoadjuvant Chemoradiation for Distal Esophageal Cancer
A. Burke (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar